Table 3 Proportion of samples submitted for mumps testing that showed previous exposure in the public and private health sectors, 2012–2017
Year | GP n (%) | KZN n (%) | MP n (%) | NW n (%) | WC n (%) | LP n (%) | FS n (%) | EC n (%) | NC n (%) | Totals n (%) |
|---|---|---|---|---|---|---|---|---|---|---|
2012 | 618 (19) | 201 (20) | 30 (15) | 15 (12) | 2 (2) | 13 (13) | 0 | 0 | 0 | 879 (100) |
2013 | 511 (15) | 186 (18) | 40 (20) | 12 (10) | 5 (5) | 31 (32) | 0 | 0 | 6 (27) | 791 (100) |
2014 | 521 (16) | 196 (19) | 32 (16) | 16 (13) | 1 (1) | 15 (15) | 5 (20) | 6 (26) | 3 (14) | 795 (100) |
2015 | 545 (16) | 158 (15) | 23 (11) | 31 (25) | 12 (12) | 12 (12) | 4 (16) | 6 (26) | 10 (45) | 795 (100) |
2016 | 519 (16) | 138 (13) | 39 (19) | 19 (15) | 41 (41) | 15 (15) | 11 (44) | 6 (26) | 3 (14) | 801 (100) |
2017 | 601 (18) | 145 (14) | 39 (19) | 33 (26) | 38 (38) | 12 (12) | 5 (20) | 5 (22) | 0 | 791 (100) |
Total | 3315 (100) | 1024 (100) | 203 (100) | 126 (100) | 99 (100) | 98 (100) | 25 (100) | 23 (100) | 22 (100) | 4935 (100) |